We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Corcept Therapeutics Inc | NASDAQ:CORT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.17 | 0.61% | 27.83 | 27.18 | 29.05 | 28.46 | 27.63 | 28.12 | 682,542 | 22:00:02 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
|
On April 1, 2015, Corcept Therapeutics Incorporated (the "Company") issued a press release announcing the exercise of outstanding warrants to purchase shares of the Company's common stock that had previously been issued by the Company to accredited investors in two private placements in March 2008 and March 2012. Collectively, the warrant exercises generated gross proceeds to the Company of $17.2 million. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01 and the information contained in the press release attached as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information in this Item 7.01 and the information contained in the press release attached as Exhibit 99.1 is not incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in the filing unless specifically stated so therein.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dated: April 02, 2015
|
CORCEPT THERAPEUTICS
By:
/s/ G. Charles Robb
|
|
|
Exhibit No. | Description |
99.1 | Press Release of Corcept Therapeutics dated April 01, 2015 |
1 Year Corcept Therapeutics Chart |
1 Month Corcept Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions